ABSTRACT
The regulation of acetylation is central for the epigenetic control of lineage-specific gene expression and determines cell fate decisions. We provide evidence that the inhibition of histone deacetylases (HDACs) blocks the endothelial differentiation of adult progenitor cells. To define the mechanisms by which HDAC inhibition prevents endothelial differentiation, we determined the expression of homeobox transcription factors and demonstrated that HoxA9 expression is down-regulated by HDAC inhibitors. The causal involvement of HoxA9 in the endothelial differentiation of adult progenitor cells is supported by the finding that HoxA9 overexpression partially rescued the endothelial differentiation blockade induced by HDAC inhibitors. Knockdown and overexpression studies revealed that HoxA9 acts as a master switch to regulate the expression of prototypical endothelial-committed genes such as endothelial nitric oxide synthase, VEGF-R2, and VE-cadherin, and mediates the shear stress-induced maturation of endothelial cells. Consistently, HoxA9-deficient mice exhibited lower numbers of endothelial progenitor cells and showed an impaired postnatal neovascularization capacity after the induction of ischemia. Thus, HoxA9 is regulated by HDACs and is critical for postnatal neovascularization.
Subject(s)
Cell Differentiation/physiology , Endothelial Cells/physiology , Gene Expression Regulation/physiology , Hematopoietic Stem Cells/physiology , Histone Deacetylases/metabolism , Homeodomain Proteins/biosynthesis , Animals , Antigens, CD , Cadherins/metabolism , Cells, Cultured , Endothelial Cells/cytology , Fetal Blood/cytology , Fetal Blood/physiology , Hematopoietic Stem Cells/cytology , Homeodomain Proteins/genetics , Humans , Ischemia/metabolism , Mice , Mice, Knockout , Neovascularization, Physiologic/genetics , Neovascularization, Physiologic/physiology , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Nitric Oxide Synthase Type III , Stress, Mechanical , Vascular Endothelial Growth Factor Receptor-2/metabolismABSTRACT
Endothelial progenitor cells (EPCs) contribute to postnatal neovascularization. Risk factors for coronary artery disease reduce the number of EPCs in humans. Since EPC apoptosis might be a potential mechanism to regulate the number of EPCs, we investigated the effects of oxidative stress and HMG-CoA-reductase inhibitors (statins) on EPC apoptosis. Atorvastatin, mevastatin, or VEGF prevented EPC apoptosis induced by H2O2. The antiapoptotic effect was reversed by inhibition of the PI3K/Akt pathway. Forkhead transcription factors (FOXO1, FOXO3a, FOXO4) exert proapoptotic effects and are phosphorylated and, thereby, inactivated by Akt. Therefore, we elucidated the involvement of forkhead transcription factors. Atorvastatin induced the phosphorylation of the predominant forkhead factor FOXO4 in EPCs. In addition, atorvastatin reduced the expression of the proapoptotic forkhead-regulated protein Bim in a PI3K-dependent manner. Consistently, overexpression of FOXO4 activated the Bim promoter as determined by reporter gene expression and stimulated the expression of Bim, resulting in an increased EPC apoptosis. Statins failed to prevent EPC apoptosis induced by overexpression of Bim or nonphosphorylatable FOXO4, suggesting that the protective effects of statins depend on this pathway. In summary, our results show that FOXO-dependent expression of Bim plays a pivotal role for EPC apoptosis. Statins reduce oxidative stress-induced EPC apoptosis, inactivate FOXO4, and down-regulate Bim.
Subject(s)
Apoptosis Regulatory Proteins/genetics , Gene Expression , Membrane Proteins/genetics , Proto-Oncogene Proteins/genetics , Transcription Factors/physiology , Apoptosis/drug effects , Apoptosis/physiology , Apoptosis Regulatory Proteins/physiology , Atorvastatin , Bcl-2-Like Protein 11 , Cell Cycle Proteins , Cell Line , Cell Survival/drug effects , Cells, Cultured , Endothelial Cells/physiology , Flow Cytometry , Forkhead Transcription Factors , Gene Expression/drug effects , Heptanoic Acids/pharmacology , Humans , Hydrogen Peroxide/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Leukocytes, Mononuclear , Membrane Proteins/physiology , Oxidative Stress , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Promoter Regions, Genetic/genetics , Proto-Oncogene Proteins/physiology , Pyrroles/pharmacology , Stem Cells/physiology , Transfection , Umbilical VeinsABSTRACT
Infusion of endothelial progenitor cells (EPC), but not of mature endothelial cells, promotes neovascularization after ischemia. We performed gene expression profiling of EPC and endothelial cells to identify genes that might be important for the neovascularization capacity of EPC. Notably, the protease cathepsin L (CathL) was highly expressed in EPC as opposed to endothelial cells and was essential for matrix degradation and invasion by EPC in vitro. CathL-deficient mice showed impaired functional recovery following hind limb ischemia, supporting the concept of a crucial role for CathL in postnatal neovascularization. Infused CathL-deficient progenitor cells neither homed to sites of ischemia nor augmented neovascularization. Forced expression of CathL in mature endothelial cells considerably enhanced their invasive activity and sufficed to confer their capacity for neovascularization in vivo. We concluded that CathL has a critical role in the integration of circulating EPC into ischemic tissue and is required for EPC-mediated neovascularization.
Subject(s)
Cathepsins/metabolism , Cysteine Endopeptidases/metabolism , Endothelial Cells/physiology , Neovascularization, Physiologic , Stem Cells/physiology , Animals , Biomarkers , Cathepsin L , Cathepsins/genetics , Cysteine Endopeptidases/genetics , Endothelial Cells/cytology , Gene Expression Profiling , Hindlimb/blood supply , Hindlimb/physiology , Humans , Ischemia/metabolism , Male , Mice , Mice, Nude , Mice, Transgenic , Oligonucleotide Array Sequence Analysis , Stem Cells/cytologyABSTRACT
Homeobox genes (Hox) encode for transcription factors, which regulate cell proliferation and migration and play an important role in the development of the cardiovascular system during embryogenesis. In this study, we investigated the role of HoxA9 for endothelial cell migration and angiogenesis in vitro and identified a novel target gene, the EphB4 receptor. Inhibition of HoxA9 expression decreased endothelial cell tube formation and inhibited endothelial cell migration, suggesting that HoxA9 regulates angiogenesis. Because Eph receptor tyrosine kinases importantly contribute to angiogenesis, we examined whether HoxA9 may transcriptionally regulate the expression of EphB4. Downregulation of HoxA9 reduced the expression of EphB4. Chromatin-immunoprecipitation revealed that HoxA9 interacted with the EphB4 promoter, whereas a deletion construct of HoxA9 without DNA-binding motif (Delta(aa) 206-272) did not bind. Consistently, HoxA9 wild-type overexpression activated the EphB4 promoter as determined by reporter gene expression. HoxA9 binds to the EphB4 promoter and stimulates its expression resulting in an increase of endothelial cell migration and tube forming activity. Thus, modulation of EphB4 expression may contribute to the proangiogenic effect of HoxA9 in endothelial cells.
